14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.55 $18.63 Wednesday, 24th Apr 2024 ACAD stock ended at $16.59. This is 0.90% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.72% from a day low at $16.55 to a day high of $16.84.
90 days $16.55 $27.94
52 weeks $16.55 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 04, 2020 $53.49 $54.90 $52.88 $54.24 707 292
Dec 03, 2020 $54.88 $55.45 $52.88 $53.28 1 086 761
Dec 02, 2020 $56.50 $56.50 $54.29 $54.73 948 019
Dec 01, 2020 $57.25 $57.25 $55.93 $56.79 931 313
Nov 30, 2020 $56.70 $56.80 $55.36 $56.66 1 184 435
Nov 27, 2020 $56.19 $56.28 $55.10 $56.00 488 369
Nov 25, 2020 $54.89 $57.46 $54.72 $55.86 1 267 495
Nov 24, 2020 $54.07 $54.84 $53.53 $54.72 1 108 852
Nov 23, 2020 $54.12 $54.21 $52.80 $53.84 643 871
Nov 20, 2020 $53.50 $53.95 $52.72 $53.57 912 002
Nov 19, 2020 $53.78 $54.24 $53.12 $53.61 671 065
Nov 18, 2020 $55.54 $55.81 $53.61 $53.82 1 042 168
Nov 17, 2020 $54.17 $55.90 $53.69 $55.29 1 295 782
Nov 16, 2020 $53.54 $55.00 $53.03 $54.63 1 793 762
Nov 13, 2020 $51.00 $51.80 $50.95 $51.57 567 422
Nov 12, 2020 $49.32 $50.88 $49.23 $50.61 756 624
Nov 11, 2020 $49.52 $49.87 $48.83 $49.07 782 007
Nov 10, 2020 $50.15 $50.46 $48.81 $49.01 1 150 332
Nov 09, 2020 $51.37 $51.90 $49.75 $50.03 1 068 865
Nov 06, 2020 $48.09 $50.50 $48.09 $50.19 965 127
Nov 05, 2020 $46.40 $49.95 $46.13 $48.56 1 580 749
Nov 04, 2020 $46.80 $50.08 $46.80 $49.13 1 849 002
Nov 03, 2020 $45.36 $46.92 $45.36 $46.60 770 743
Nov 02, 2020 $46.50 $46.56 $44.78 $45.64 787 863
Oct 30, 2020 $46.80 $47.67 $45.35 $46.45 1 313 470
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT